MX355416B - Biomarcadores de cancer de pulmon y usos de los mismos. - Google Patents

Biomarcadores de cancer de pulmon y usos de los mismos.

Info

Publication number
MX355416B
MX355416B MX2014004860A MX2014004860A MX355416B MX 355416 B MX355416 B MX 355416B MX 2014004860 A MX2014004860 A MX 2014004860A MX 2014004860 A MX2014004860 A MX 2014004860A MX 355416 B MX355416 B MX 355416B
Authority
MX
Mexico
Prior art keywords
lung cancer
cancer biomarkers
individual
level
nsclc
Prior art date
Application number
MX2014004860A
Other languages
English (en)
Spanish (es)
Other versions
MX2014004860A (es
Inventor
Alaric Williams Stephen
Riel-Mehan Michael
N Brody Edward
A E Stewart Alex
M Ostroff Rachel
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of MX2014004860A publication Critical patent/MX2014004860A/es
Publication of MX355416B publication Critical patent/MX355416B/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
MX2014004860A 2011-10-24 2011-10-24 Biomarcadores de cancer de pulmon y usos de los mismos. MX355416B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/057499 WO2013062515A2 (en) 2011-10-24 2011-10-24 Lung cancer biomarkers and uses thereof

Publications (2)

Publication Number Publication Date
MX2014004860A MX2014004860A (es) 2014-05-27
MX355416B true MX355416B (es) 2018-04-18

Family

ID=48168748

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004860A MX355416B (es) 2011-10-24 2011-10-24 Biomarcadores de cancer de pulmon y usos de los mismos.

Country Status (15)

Country Link
EP (1) EP2771692B1 (https=)
JP (1) JP5986638B2 (https=)
KR (1) KR101921945B1 (https=)
CN (2) CN103890586B (https=)
AU (1) AU2011378427B8 (https=)
BR (1) BR112014006432B8 (https=)
CA (3) CA3064363C (https=)
ES (1) ES2674318T3 (https=)
IL (2) IL231426A (https=)
IN (1) IN2014CN01787A (https=)
MX (1) MX355416B (https=)
NZ (1) NZ621733A (https=)
SG (1) SG11201400375SA (https=)
WO (1) WO2013062515A2 (https=)
ZA (1) ZA201401476B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012006632A2 (en) 2010-07-09 2012-01-12 Somalogic, Inc. Lung cancer biomarkers and uses thereof
AU2013388864B2 (en) * 2013-05-09 2017-06-08 The Procter & Gamble Company Method and system for assessing health condition
CN112029826B (zh) 2014-07-30 2025-03-14 哈佛学院院长及董事 用于测定核酸的系统和方法
CN104263723B (zh) * 2014-09-15 2017-06-06 南京医科大学 一种与原发性肺癌辅助诊断相关的低频高外显性遗传标志物及其应用
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
JP6857185B2 (ja) * 2015-09-11 2021-04-14 アプタマー サイエンス インコーポレイテッドAptamer Sciences Inc. 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法
EP3372686B1 (en) * 2015-11-05 2020-05-20 BGI Shenzhen Biomarker for detection of lung adenocarcinoma and use thereof
EP4339288A3 (en) * 2016-03-18 2024-06-05 Caris Science, Inc. Oligonucleotide probes and uses thereof
KR101853118B1 (ko) * 2016-09-02 2018-04-30 주식회사 바이오인프라생명과학 피험체의 폐암 진단을 위한 복합 바이오마커군, 이를 이용하는 폐암 진단용 키트, 복합 바이오마커군의 정보를 이용하는 방법 및 이를 수행하는 컴퓨팅 시스템
CN116732143A (zh) * 2016-11-08 2023-09-12 哈佛学院院长及董事 基质印迹和清除
JP7128196B2 (ja) * 2017-03-01 2022-08-30 エフ.ホフマン-ラ ロシュ アーゲー 検体の存在に関する生体サンプルの分類のためのシステムおよび方法
WO2018218150A1 (en) 2017-05-26 2018-11-29 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109470859A (zh) * 2018-11-04 2019-03-15 华东医院 一种外泌体蛋白作为鉴别肺结节良恶性标志物及其应用
CA3122569A1 (en) 2018-12-13 2020-06-18 President And Fellows Of Harvard College Amplification methods and systems for merfish and other applications
EP3671210A1 (en) * 2018-12-21 2020-06-24 Biosystems International KFT Lung cancer protein epitomic biomarkers
US20220341939A1 (en) * 2019-02-15 2022-10-27 Biodesix, Inc. Predictive test for identification of early stage nsclc stage patients at high risk of recurrence after surgery
CN110473167B (zh) * 2019-07-09 2022-06-17 哈尔滨工程大学 一种基于深度学习的尿沉渣图像识别系统及方法
CN112892619B (zh) * 2019-12-04 2022-07-15 香港城市大学深圳研究院 弧形边缘截面的pdms母模、微流控阀和芯片及其制备
WO2022103843A1 (en) * 2020-11-11 2022-05-19 George Mason Research Foundation, Inc. Laser capture microdissection visualization chemistry
KR102613772B1 (ko) * 2021-02-02 2023-12-14 제노마인(주) 폐암 혈액 바이오마커의 검출 방법 및 키트
WO2025144995A1 (en) * 2023-12-29 2025-07-03 Novelna Inc. Lung cancer detection proteins and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335170B1 (en) * 1999-02-22 2002-01-01 Torben F. Orntoft Gene expression in bladder tumors
US6596503B1 (en) * 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
JP4874234B2 (ja) * 2004-08-10 2012-02-15 オンコセラピー・サイエンス株式会社 非小細胞肺癌関連遺伝子ANLN、およびそのRhoAとの相互作用
CN101283106A (zh) * 2005-07-27 2008-10-08 肿瘤疗法科学股份有限公司 小细胞肺癌的诊断方法
EP1937837A2 (en) 2005-07-29 2008-07-02 Siemens Healthcare Diagnostics Inc. Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
US8445198B2 (en) * 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
WO2008046911A2 (en) * 2006-10-20 2008-04-24 Exiqon A/S Novel human micrornas associated with cancer
GB0803192D0 (en) * 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
CA3152591C (en) * 2008-09-09 2023-08-29 Somalogic Operating Co., Inc. Lung cancer biomarkers and uses thereof
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
WO2011109440A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
WO2010056374A2 (en) 2008-11-17 2010-05-20 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
CA2745961A1 (en) * 2008-12-04 2010-06-10 The Regents Of The University Of California Materials and methods for determining diagnosis and prognosis of prostate cancer
US9624547B2 (en) * 2010-02-10 2017-04-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease

Also Published As

Publication number Publication date
BR112014006432B8 (pt) 2022-10-25
NZ621733A (en) 2015-05-29
IL231426A0 (en) 2014-04-30
EP2771692A2 (en) 2014-09-03
CA3006793A1 (en) 2013-05-02
IL231426A (en) 2017-06-29
EP2771692A4 (en) 2015-08-26
JP2015501154A (ja) 2015-01-15
IL252163A0 (en) 2017-07-31
CA2847188C (en) 2020-02-18
ES2674318T3 (es) 2018-06-28
ZA201401476B (en) 2016-06-29
IN2014CN01787A (https=) 2015-05-29
BR112014006432A2 (pt) 2017-04-04
WO2013062515A2 (en) 2013-05-02
MX2014004860A (es) 2014-05-27
CA2847188A1 (en) 2013-05-02
AU2011378427B2 (en) 2015-07-16
CN106168624B (zh) 2018-03-13
CN103890586A (zh) 2014-06-25
CA3064363C (en) 2022-05-17
CA3006793C (en) 2020-02-18
WO2013062515A3 (en) 2014-04-17
CA3064363A1 (en) 2013-05-02
AU2011378427A8 (en) 2015-08-27
CN106168624A (zh) 2016-11-30
EP2771692B1 (en) 2018-04-18
BR112014006432B1 (pt) 2021-04-06
CN103890586B (zh) 2016-06-29
AU2011378427A1 (en) 2013-05-16
KR101921945B1 (ko) 2018-11-26
KR20140082840A (ko) 2014-07-02
SG11201400375SA (en) 2014-04-28
AU2011378427B8 (en) 2015-08-27
JP5986638B2 (ja) 2016-09-06

Similar Documents

Publication Publication Date Title
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
MX340453B (es) Biomarcadores para cancer de pulmon.
MX355020B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
EA201590027A1 (ru) Способы детекции заболеваний или состояний
AR090973A1 (es) Anticuerpos utiles para el diagnostico del cancer
HK1214652A1 (zh) 用於检测胰腺癌的方法和组合物
WO2013022786A3 (en) Microrna biomarkers
TN2013000464A1 (en) Biomarkers for hedgehog inhibitor therapy
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EP4060048A3 (en) Non-invasive diagnostic method for diagnosing bladder cancer
HK1200037A1 (en) Non-invasive methods of detecting target molecules
WO2013066369A3 (en) Methods for detecting graft-versus-host disease
WO2012021887A3 (en) Biomarkers for the early detection of breast cancer
EA201690213A1 (ru) Композиции и способ лечения связанных с комплементом состояний
MX2013003077A (es) Diagnostico de cancer de mama.
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
CR20110530A (es) Dispositivo y procedimiento para la verificación y para el análisis cuantitativo de analitos, particularmente de micotoxinas
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
HUE045731T2 (hu) Mikro-RNS biomarkerek tüdõtumor diagnosztizálásához és/vagy kockázatának azonosításához
WO2013124738A3 (en) Methods and biomarkers for detection and prognosis of cervical cancer
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
MX360479B (es) Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs.
NZ712023A (en) Caix stratification based cancer treatment

Legal Events

Date Code Title Description
FG Grant or registration